Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 20382196)

1.

Serum IL-7 and G-CSF in major depressive disorder.

Lehto SM, Huotari A, Niskanen L, Herzig KH, Tolmunen T, Viinamäki H, Koivumaa-Honkanen H, Honkalampi K, Sinikallio S, Ruotsalainen H, Hintikka J.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):846-51. doi: 10.1016/j.pnpbp.2010.03.033. Epub 2010 Apr 8.

PMID:
20382196
2.

Serum chemokine levels in major depressive disorder.

Lehto SM, Niskanen L, Herzig KH, Tolmunen T, Huotari A, Viinamäki H, Koivumaa-Honkanen H, Honkalampi K, Ruotsalainen H, Hintikka J.

Psychoneuroendocrinology. 2010 Feb;35(2):226-32. doi: 10.1016/j.psyneuen.2009.06.007. Epub 2009 Jul 9.

PMID:
19592174
3.

Serum adiponectin and resistin levels in major depressive disorder.

Lehto SM, Huotari A, Niskanen L, Tolmunen T, Koivumaa-Honkanen H, Honkalampi K, Ruotsalainen H, Herzig KH, Viinamäki H, Hintikka J.

Acta Psychiatr Scand. 2010 Mar;121(3):209-15. doi: 10.1111/j.1600-0447.2009.01463.x. Epub 2009 Aug 19.

PMID:
19694629
4.

Differences in cytokines between non-suicidal patients and suicidal patients in major depression.

Kim YK, Lee SW, Kim SH, Shim SH, Han SW, Choi SH, Lee BH.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):356-61. Epub 2007 Sep 5.

PMID:
17919797
5.

Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA).

van Reedt Dortland AK, Giltay EJ, van Veen T, van Pelt J, Zitman FG, Penninx BW.

J Clin Psychiatry. 2010 Jun;71(6):729-36. doi: 10.4088/JCP.08m04865blu. Epub 2009 Dec 15.

PMID:
20021996
6.

Anger attacks in major depressive disorder and serum levels of homocysteine.

Fraguas R Jr, Papakostas GI, Mischoulon D, Bottiglieri T, Alpert J, Fava M.

Biol Psychiatry. 2006 Aug 1;60(3):270-4. Epub 2005 Dec 1.

PMID:
16325154
8.

Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.

Reisbach G, Kamp T, Welzl G, Geiz C, Abedinpour Fariborz, Lodri A, Kaboth W, Dörmer P, Nerl C.

Br J Haematol. 1996 Mar;92(4):907-12.

PMID:
8616084
9.

Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression.

Dhabhar FS, Burke HM, Epel ES, Mellon SH, Rosser R, Reus VI, Wolkowitz OM.

J Psychiatr Res. 2009 Jul;43(11):962-9. doi: 10.1016/j.jpsychires.2009.05.010. Epub 2009 Jun 23.

PMID:
19552919
10.

Low serum HDL-cholesterol levels are associated with long symptom duration in patients with major depressive disorder.

Lehto SM, Niskanen L, Tolmunen T, Hintikka J, Viinamäki H, Heiskanen T, Honkalampi K, Kokkonen M, Koivumaa-Honkanen H.

Psychiatry Clin Neurosci. 2010 Jun;64(3):279-83. doi: 10.1111/j.1440-1819.2010.02079.x. Epub 2010 Mar 30.

PMID:
20374538
11.

T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression.

Huang TL, Lee CT.

Psychiatry Clin Neurosci. 2007 Aug;61(4):415-20.

PMID:
17610667
12.

Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L, Hansson O, Björkqvist M, Träskman-Bendz L, Brundin L.

Biol Psychiatry. 2009 Aug 1;66(3):287-92. doi: 10.1016/j.biopsych.2009.01.030. Epub 2009 Mar 6.

PMID:
19268915
13.

High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis.

Nakamura H, Ueki Y, Sakito S, Matsumoto K, Yano M, Miyake S, Tominaga T, Tominaga M, Eguchi K.

Clin Exp Rheumatol. 2000 Nov-Dec;18(6):713-8.

PMID:
11138333
14.

Increase in interleukin-1beta in late-life depression.

Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT.

Am J Psychiatry. 2005 Jan;162(1):175-7.

PMID:
15625217
15.

Inflammatory markers and sleep disturbance in major depression.

Motivala SJ, Sarfatti A, Olmos L, Irwin MR.

Psychosom Med. 2005 Mar-Apr;67(2):187-94.

PMID:
15784782
16.

Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder.

Hernández ME, Mendieta D, Martínez-Fong D, Loría F, Moreno J, Estrada I, Bojalil R, Pavón L.

Eur Neuropsychopharmacol. 2008 Dec;18(12):917-24. doi: 10.1016/j.euroneuro.2008.08.001. Epub 2008 Sep 20.

PMID:
18805677
17.

Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder.

Kahl KG, Bester M, Greggersen W, Rudolf S, Dibbelt L, Stoeckelhuber BM, Gehl HB, Sipos V, Hohagen F, Schweiger U.

Psychosom Med. 2005 May-Jun;67(3):407-12.

PMID:
15911903
18.

Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder.

Elomaa AP, Niskanen L, Herzig KH, Viinamäki H, Hintikka J, Koivumaa-Honkanen H, Honkalampi K, Valkonen-Korhonen M, Harvima IT, Lehto SM.

BMC Psychiatry. 2012 Jan 9;12:2. doi: 10.1186/1471-244X-12-2.

19.

Immunological differences between patients with major depression and somatization syndrome.

Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M.

Psychiatry Res. 2001 Dec 31;105(3):165-74.

PMID:
11814536
20.

Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.

Sasayama D, Hattori K, Wakabayashi C, Teraishi T, Hori H, Ota M, Yoshida S, Arima K, Higuchi T, Amano N, Kunugi H.

J Psychiatr Res. 2013 Mar;47(3):401-6. doi: 10.1016/j.jpsychires.2012.12.001. Epub 2013 Jan 3.

PMID:
23290488
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk